Meeting people where they are is about much more than location: Delivering hepatitis C care and treatment to people who use drugs. Community pharmacists: Underutilized resources in the HIV care team. Anal sex is a common practice among men who have sex with men, heterosexual men and women, and transgender individuals and is a known risk factor for HIV infection and transmission. Therefore, it is important that education on HIV prevention includes accurate information on the fluids that can transmit HIV through this type of sex.
What Is the Risk of HIV From Vaginal Sex?
vaginal sex, then anal sex, back to vaginal sex | TheBody
However, there are different potential risks that may not be present in vaginal or oral sex. For example, the anus cannot naturally lubricate itself to reduce discomfort and friction-related concerns, such as skin injuries. This article will discuss some of the potential risks of anal sex as well as dispel some myths related to the practice. The anus lacks the cells that create the natural lubricant the vagina has. It also does not have the saliva of the mouth. The rectum's lining is also thinner than that of the vagina.
Anal Sex and HIV Risk
The risk of acquiring HIV through unprotected anal sex is at least 20 times greater than with unprotected vaginal sex and increases if other infections are already present in the rectal lining. Could the use of lubricants -- at least certain kinds -- be another risk factor among men and women who engage in receptive anal intercourse? Two studies presented at the International Microbicides Conference in Pittsburgh, suggest the answer is yes. In one study involving nearly men and women in Baltimore and Los Angeles, the researchers found that those who used lubricants were three times more likely to have rectal sexually transmitted infections STIs. Another study that subjected popular over-the-counter and mail-order lubricants to rigorous laboratory tests discovered that many of the products were toxic to cells and rectal tissue.
Meeting people where they are is about much more than location: Delivering hepatitis C care and treatment to people who use drugs. Community pharmacists: Underutilized resources in the HIV care team. What do the latest studies tell us about this risk? And how should we interpret and communicate the results?